Rilutek 50mg Tablets

Rilutek 50 mg Tablets contain riluzole, a prescription medicine used to treat amyotrophic lateral sclerosis (ALS), also known as motor neurone disease. Riluzole acts on the nervous system and is used to help extend survival or delay the need for mechanical ventilation in eligible patients with ALS.

Rilutek is intended for use under the supervision of a specialist experienced in managing motor neurone disease. It does not cure ALS, and its ability to improve existing motor symptoms has not been established.

Product Information

Product Name

Rilutek 50 mg Tablets

Active Ingredient

Riluzole

Strength

50 mg per tablet

Dosage Form

Film-coated tablet

Drug Class

Neurological medicine

Therapeutic Category

Antisclerotic agent for ALS

Indication

Amyotrophic lateral sclerosis (ALS)

Route of Administration

Oral

Prescription Requirement

Prescription-only, subject to local regulations

Pack Size

Confirm the available packaging

Ordering and Availability

For Rilutek 50 mg tablet pricing, pack sizes and availability, contact the supplier to confirm the exact product, manufacturer, current stock and supporting documentation.

Product authorization, prescription requirements and import eligibility vary by country. Verify the applicable local rules and obtain the medicine through an authorized pharmacy or eligible supplier.

Rilutek 50 mg Tablets are prescribed for:

• Amyotrophic Lateral Sclerosis (ALS): Used in the management of this progressive neurological condition.
• Survival Support: Treatment may help extend survival or delay the need for mechanical ventilation in patients with ALS.

Rilutek is not a cure for ALS and is not established as a treatment for other forms of motor neurone disease. A specialist should determine whether treatment is appropriate.

The recommended adult dose in the US and European product information is generally 50 mg twice daily, approximately 12 hours apart.

Rilutek tablets should be taken at least one hour before or two hours after a meal, according to the prescribing instructions. Follow the exact directions provided by the treating specialist and the product leaflet.

Do not increase the dose, change the treatment schedule or discontinue riluzole without medical advice.

Storage Instructions

Store Rilutek according to the manufacturer's packaging and patient information leaflet. Keep the tablets in their original packaging where appropriate, away from children and unsuitable storage conditions.

Do not use the medicine after the stated expiry date.

Possible side effects include:

• Nausea and vomiting
• Dizziness
• Weakness or fatigue
• Abdominal pain
• Changes in liver-function test results
• Reduced lung function

Seek prompt medical advice for fever or signs of infection, worsening breathing symptoms, jaundice, dark urine or persistent abdominal pain. Serious adverse reactions require urgent medical assessment.

Rilutek requires medical supervision and regular monitoring.

• Liver function: Liver enzymes should be checked before treatment and regularly during treatment. Liver injury, including hepatitis, has been reported.
• Blood disorders: Report fever or signs of infection promptly, as neutropenia has been reported.
• Lung complications: New cough or difficulty breathing requires medical assessment because interstitial lung disease has been reported.
• Drug interactions: Tell the prescriber about all medicines, particularly medicines that may affect liver function or riluzole metabolism.
• Pregnancy and breastfeeding: Discuss potential risks and benefits with a healthcare professional before use.

Rilutek should not be used by people with a history of severe hypersensitivity to riluzole or its ingredients. Refer to the official product information for the full contraindications and precautions.